SSA
MDCO

Schonfeld Strategic Advisors’s Medicines Co MDCO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,191
Closed -$951K – 1705
2019
Q4 		$951K Buy
11,191
+6,091
+119% +$406K 0.02% 526
2019
Q3 		$255K Buy
+5,100
New +$203K 0.01% 834
2017
Q2 		– Sell
-10,000
Closed -$489K – 848
2017
Q1 		$489K Buy
10,000
+3,485
+53% +$159K 0.05% 374
2016
Q4 		$222K Buy
+6,515
New +$231K 0.03% 487

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Schonfeld Strategic Advisors's MDCO Position: Q1 2020 in Review

Schonfeld Strategic Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 11,191 shares — an estimated $951K sold.

Schonfeld Strategic Advisors first reported a position in MDCO in Q4 2016 and held it in 4 quarters. The position peaked at $951K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Schonfeld Strategic Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 11,191 Medicines Co shares in Q1 2020, an estimated $951K.
  • Schonfeld Strategic Advisors first reported a position in Medicines Co in Q4 2016 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Medicines Co position peaked at $951K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2020, filed 15 May 2020.